These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35727945)

  • 1. The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
    Arrambide G; Espejo C; Carbonell-Mirabent P; Dieli-Crimi R; Rodríguez-Barranco M; Castillo M; Auger C; Cárdenas-Robledo S; Castilló J; Cobo-Calvo Á; Galán I; Midaglia L; Nos C; Otero-Romero S; Río J; Rodríguez-Acevedo B; Ruiz-Ortiz M; Salerno A; Tagliani P; Tur C; Vidal-Jordana A; Zabalza A; Sastre-Garriga J; Rovira A; Comabella M; Hernández-González M; Montalban X; Tintore M
    Brain; 2022 Nov; 145(11):3931-3942. PubMed ID: 35727945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Arrambide G; Tintore M; Espejo C; Auger C; Castillo M; Río J; Castilló J; Vidal-Jordana A; Galán I; Nos C; Mitjana R; Mulero P; de Barros A; Rodríguez-Acevedo B; Midaglia L; Sastre-Garriga J; Rovira A; Comabella M; Montalban X
    Brain; 2018 Apr; 141(4):1075-1084. PubMed ID: 29462277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
    Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
    Zeman D; Hradilek P; Kusnierova P; Piza R; Reguliova K; Woznicova I; Zapletalova O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):104-13. PubMed ID: 25485529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis.
    Ferraro D; Trovati A; Bedin R; Natali P; Franciotta D; Santangelo M; Camera V; Vitetta F; Varani M; Trenti T; Gastaldi M; De Biasi S; Nasi M; Pinti M; Meletti S; Sola P
    Eur J Neurol; 2020 Mar; 27(3):461-467. PubMed ID: 31710409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin class and light chain type of oligoclonal bands in CSF in multiple sclerosis determined by agarose gel electrophoresis and immunofixation.
    Link H; Laurenzi MA
    Ann Neurol; 1979 Aug; 6(2):107-10. PubMed ID: 115379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.
    Gurtner KM; Shosha E; Bryant SC; Andreguetto BD; Murray DL; Pittock SJ; Willrich MAV
    Clin Chem Lab Med; 2018 Jun; 56(7):1071-1080. PubMed ID: 29455184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
    Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
    Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
    Presslauer S; Milosavljevic D; Brücke T; Bayer P; Hübl W
    J Neurol; 2008 Oct; 255(10):1508-14. PubMed ID: 18685917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG Index Revisited: Diagnostic Utility and Prognostic Value in Multiple Sclerosis.
    Zheng Y; Cai MT; Yang F; Zhou JP; Fang W; Shen CH; Zhang YX; Ding MP
    Front Immunol; 2020; 11():1799. PubMed ID: 32973754
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI.
    Frederiksen JL; Sindic CJ
    Mult Scler; 1998 Feb; 4(1):22-6. PubMed ID: 9532588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
    Hegen H; Walde J; Berek K; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):169-181. PubMed ID: 36453167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic value of immunoglobulin free light chains at the debut of multiple sclerosis].
    Nazarov VD; Makshakov GS; Mazing AV; Surkova EA; Krasnov VS; Shumilina MV; Totolyan NA; Evdoshenko EP; Lapin SV; Emanuel VL; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2. Vyp. 2):60-65. PubMed ID: 28617363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: use of light-chain typing to assist diagnosis.
    Jenkins MA; Cheng L; Ratnaike S
    Ann Clin Biochem; 2001 May; 38(Pt 3):235-41. PubMed ID: 11392498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
    Hegen H; Arrambide G; Gnanapavan S; Kaplan B; Khalil M; Saadeh R; Teunissen C; Tumani H; Villar LM; Willrich MAV; Zetterberg H; Deisenhammer F
    Mult Scler; 2023 Feb; 29(2):182-195. PubMed ID: 36527368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.